Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT05707546
Other study ID # N6
Secondary ID
Status Completed
Phase
First received
Last updated
Start date January 28, 2023
Est. completion date July 15, 2023

Study information

Verified date January 2024
Source University of Thessaly
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

The purpose of current research study is to assess physiotherapists's knowledge, beliefs and attitudes about empathy, motivational interviewing and shared decision making in chronic musculoskeletal patients. An e-survey study will be conducted based on Checklist for Reporting Results of 52 Internet E-Surveys (CHERRIES)


Description:

The main questions it aims to answer are: What physiotherapists know about the use of empathy, motivational interviewing and shared decision making? What beliefs do physiotherapists have about the appropriate use of communication skills? Whether and how much they use empathy, motivational interview, shared decision-making in clinical practice? What are the main barriers of using communication skills (empathy, motivational interview, joint decision-making) in clinical practice?


Recruitment information / eligibility

Status Completed
Enrollment 257
Est. completion date July 15, 2023
Est. primary completion date July 15, 2023
Accepts healthy volunteers No
Gender All
Age group 18 Years to 65 Years
Eligibility Inclusion Criteria: - Physiotherapists who are member of Panhellenic Association of Physiotherapist in Greece, with active clinical practice in Greece and clinical experience in musculoskeletal disorders (>12 months). Exclusion Criteria: - None

Study Design


Related Conditions & MeSH terms


Locations

Country Name City State
Greece University of Thessaly Lamia

Sponsors (1)

Lead Sponsor Collaborator
University of Thessaly

Country where clinical trial is conducted

Greece, 

Outcome

Type Measure Description Time frame Safety issue
Primary Demographic characteristics Questions will include participants' demographic characteristics (e.g. gender, age), 2) the setting where they practice their profession (e.g. hospital, private physiotherapy clinic), 3) level of education (e.g. BSc, MSc), 5) their years of practice, 6) seminars or training programs they have attended regarding pain neuroscience education. Baseline
Primary Knowledge about Empathy A structure questionnaire will be used which included
A question about how much do they know about empathetic behaviour, using a 10-point Likert scale (0=I don't know anything about the empathetic behaviour and 10=I have comprehensive knowledge on the empathetic behaviour)"
Toronto Composite Empathy Scale. The scale contains 26 statements scored on the Likert Scale (1=never, 2=sometimes, 3=less than half the time, 4=more than half the time, 5=almost all times, and 6=always). The scale demonstrated acceptable validity and reliability. The overall reliability analysis of the TCES questionnaire in Greek is high (Cronbach's a = 0.895, Sig. from Hotelling's T-Squared Test < 0.000).
Baseline
Primary Beliefs about Empathy Question about how much do they believe the empathetic behaviour is useful in the treatment of chronic musculoskeletal patients, using a 6-point Likert scale (0=completely disagree and 10=completely agree). Baseline
Primary Attitude about Empathy A question about the using of the empathetic behaviour in the treatment of chronic musculoskeletal patients, using a 6-point Likert scale (0=completely disagree and 10=completely agree). Baseline
Primary Barriers about Empathy 9 statements with specific barriers of showing empathy in the treatment of chronic musculoskeletal patients, using a 6-point Likert scale, where 0=completely disagree and 10=completely agree and an open question about other barriers. Baseline
Primary Knowledge about Shared-Decision Making A structure questionnaire will be used which included
A question about how much do they know about the using of Shared-Decision Making, using a 10-point Likert scale (0=I don't know anything about this concept and 10=I have comprehensive knowledge about this concept)"
The 9-item Shared Decision Making Questionnaire (SDM-Q-9). The scale demonstrated acceptable validity and reliability, a Cronbach's alpha of 0.938 in the test sample.
Baseline
Primary Beliefs about Shared-Decision Making A question about how much do they believe Shared-Decision Making is useful in the treatment planning of chronic musculoskeletal patients, using a 6-point Likert scale (0=completely disagree and 10=completely agree). Baseline
Primary Attitude about Shared-Decision Making A question about the using of Shared-Decision Making in the treatment planning of chronic musculoskeletal patients, using a 6-point Likert scale (0=completely disagree and 10=completely agree). Baseline
Primary Barriers about Shared-Decision Making 5 statements with specific barriers of using Shared-Decision Making in the treatment planning of chronic musculoskeletal patients, using a 6-point Likert scale, where 0=completely disagree and 10=completely agree and an open question about other barriers. Baseline
Primary Knowledge about Motivational Interviewing A structure questionnaire will be used which included
A question about how much do they know about the using of Motivational Interviewing, using a 10-point Likert scale (0=I don't know anything about this concept and 10=I have comprehensive knowledge about this concept)"
The Motivational Interviewing Knowledge and Attitudes Test The Motivational which included true/false statements assessing knowledge of motivational interviewing principles and attitudes associated with behaviour change and the statements will be adapted for chronic musculoskeletal patients.
Baseline
Primary Beliefs about Motivational Interviewing A question about how much do they believe Motivational Interviewing is useful in the treatment of chronic musculoskeletal patients, using a 6-point Likert scale (0=completely disagree and 10=completely agree). Baseline
Primary Attitude about Motivational Interviewing A question about the using of Motivational Interviewing in the treatment of chronic musculoskeletal patients, using a 6-point Likert scale (0=completely disagree and 10=completely agree). Baseline
Primary Barriers about Motivational Interviewing 5 statements with specific barriers of using Motivational Interviewing in the treatment of chronic musculoskeletal patients, using a 6-point Likert scale, where 0=completely disagree and 10=completely agree and an open question about other barriers. Baseline
See also
  Status Clinical Trial Phase
Completed NCT01659073 - Using Perfusion MRI to Measure the Dynamic Changes in Neural Activation Associated With Caloric Vestibular Stimulation N/A
Recruiting NCT05914311 - Use of Dermabond in Mitigation of Spinal Cord Stimulation (SCS) Trial Lead Migration N/A
Recruiting NCT05422456 - The Turkish Version of Functional Disability Inventory
Enrolling by invitation NCT05422443 - The Turkish Version of Pain Coping Questionnaire
Completed NCT05057988 - Virtual Empowered Relief for Chronic Pain N/A
Completed NCT04385030 - Neurostimulation and Mirror Therapy in Traumatic Brachial Plexus Injury N/A
Recruiting NCT06206252 - Can Medical Cannabis Affect Opioid Use?
Completed NCT05103319 - Simultaneous Application of Ketamine and Lidocaine During an Ambulatory Infusion Therapy as a Treatment Option in Refractory Chronic Pain Conditions
Completed NCT03687762 - Back on Track to Healthy Living Study N/A
Completed NCT04171336 - Animal-assisted Therapy for Children and Adolescents With Chronic Pain N/A
Completed NCT03179475 - Targin® for Chronic Pain Management in Patients With Spinal Cord Injury Phase 4
Completed NCT03418129 - Neuromodulatory Treatments for Pain Management in TBI N/A
Completed NCT03268551 - MEMO-Medical Marijuana and Opioids Study
Recruiting NCT06204627 - TDCS* and Laterality Trainnning in Patients With Chronic Neck Pain N/A
Recruiting NCT06060028 - The Power of Touch. Non-Invasive C-Tactile Stimulation for Chronic Osteoarthritis Pain N/A
Completed NCT05496205 - A SAD Study to Evaluate the Safety, Tolerability and PK/PD of iN1011-N17 in Healthy Volunteers Phase 1
Completed NCT00983385 - Evaluation of Effectiveness and Tolerability of Tapentadol Hydrochloride in Subjects With Severe Chronic Low Back Pain Taking Either WHO Step I or Step II Analgesics or no Regular Analgesics Phase 3
Recruiting NCT05118204 - Randomized Trial of Buprenorphine Microdose Inductions During Hospitalization Phase 4
Terminated NCT03538444 - Repetitive Transcranial Magnetic Stimulation for Opiate Use Disorder N/A
Not yet recruiting NCT05812703 - Biometrics and Self-reported Health Changes in Adults Receiving Behavioral Treatments for Chronic Pain